GSK vs INVE · P/E 13, $103.31B cap vs rev $13.1M
GlaxoSmithKline PLC ADR (GSK) versus Identiv Inc (INVE) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Identiv Inc (INVE) is a building products & equipment company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported INVE revenue for 2026-06-30 was $13.1M. Net income was -$8.1M. Revenue was up 76.6% from 2026-03-31 to 2026-06-30. INVE currently screens at market cap $96.3M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. INVE currently screens at market cap $96.3M.
Not investment advice. Open the GSK and INVE stock pages for the full models.
Not investment advice.